Invasive Fungal Infections Recruiting Phase 2 Trials for Olorofim (DB15245)

Also known as: Invasive Fungal Infection / Invasive Mycosis / Invasive Infection, Fungal / Infection, Invasive Fungal / Invasive Fungal Disease / Fungal Invasive Disease / Invasive fungal infection (disorder) / Systemic fungal infection NOS / Disseminated mycosis / Systemic mycosis / Systemic mycosis (disorder)

IndicationStatusPhase
DBCOND0030131 (Invasive Fungal Infections)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03583164Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment OptionsTreatment